Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 473-480

  Boulenouar, Selma ^a   Weyn, Christine ^a   van Noppen, Melody ^a   Ali, Mohamed Moussa ^a   Favre, Michel ^b   Delvenne, Philippe O ^c   Bex, Francxoise ^a   Noël, Agnès ^c   Englert, Yvon ^a   Fontaine, Véronique ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN E5; PROTEIN E6; PROTEIN E7; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; UVOMORULIN; VIRUS PROTEIN; CADHERIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E5, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; TUMOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; NONHUMAN; OPEN READING FRAME; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; BIOSYNTHESIS; CANCER INVASION; CHEMOTAXIS; CYTOLOGY; CYTOPATHOGENIC EFFECT; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOGENICITY; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR; UTERUS CANCER; VIROLOGY;

CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CHEMOTAXIS; CHORIOCARCINOMA; CYTOPATHOGENIC EFFECT, VIRAL; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PHENOTYPE; REPRESSOR PROTEINS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 77950907927     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp281     Document Type: Article

References (60)

1. Zur Hausen, H. (2009) Papillomaviruses in the causation of human cancers a brief historical account. Virology, 384, 260-265.
2. Hebner, C.M. et al. (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol., 16, 83-97.
3. Huibregtse, J.M. et al. (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J., 10, 4129-4135.
4. Lee, S.S. et al. (2000) Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol., 74, 9680-9693.
5. Gardiol, D. et al. (1999) Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene, 18, 5487-5496.
6. Nakagawa, S. et al. (2000) Human scribble (Vartul) is targeted for ubiquitinmediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol., 20, 8244-8253.
7. Thomas, M. et al. (2002) Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene, 21, 5088-5096.
8. Jackson, S. et al. (2000) Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev., 14, 3065-3073.
9. Garnett, T.O. et al. (2006) Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAILmediated apoptosis. Cell Death Differ., 13, 1915-1926.
10. Katzenellenbogen, R.A. et al. (2007) NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells. J. Virol., 81, 3786-3796.
11. Munger, K. et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-7898.
12. Ishikawa, M. et al. (2006) Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int. J. Gynecol. Cancer, 16, 347-353.
13. Hubert, P. et al. (2005) E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol., 206, 346-355.
14. Caberg, J.H. et al. (2008) Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis, 29, 1441-1447.
15. Matthews, K. et al. (2003) Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J. Virol., 77, 8378-8385.
16. Yap, A.S. et al. (1997) Molecular and functional analysis of cadherin-based adherens junctions. Annu. Rev. Cell Dev. Biol., 13, 119-146.
17. Al Moustafa, A.E. et al. (2008) High-risk HPV/ErbB-2 interaction on Ecadherin/catenin regulation in human carcinogenesis. Curr. Pharm. Des., 14, 2159-2172.
18. Follen, M. et al. (2001) Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials. Cancer, 91, 1758-1776.
19. Conrad, M. et al. (1993) The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16kilodalton pore-forming protein. J. Virol., 67, 6170-6178.
20. Straight, S.W. et al. (1995) The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol., 69, 3185-3192.
21. Bouvard, V. et al. (1994) The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology, 203, 73-80.
22. Stoppler, M.C. et al. (1996) The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology, 223, 251-254.
23. Genther Williams, S.M. et al. (2005) Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res., 65, 6534-6542.
24. Lewis, C. et al. (2008) The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth. Virol J., 5, 30.
25. Krawczyk, E. et al. (2008) Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am. J. Pathol., 173, 682-688.
26. Bravo, I.G. et al. (2005) The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes. Arch. Virol., 150, 231-246.
27. Suprynowicz, F.A. et al. (2008) HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene, 27, 6396.
28. Oelze, I. et al. (1995) Human papillomavirus type 16 E5 protein affects cellcell communication in an epithelial cell line. J. Virol., 69, 4489-4494.
29. Tomakidi, P. et al. (2000) Connexin 43 expression is downregulated in raft cultures of human keratinocytes expressing the human papillomavirus type 16 E5 protein. Cell Tissue Res., 301, 323-327.
30. Kivi, N. et al. (2008) Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression. Oncogene, 27, 2532-2541.
31. You, H. et al. (2008) Multiple human papillomavirus types replicate in 3A trophoblasts. Placenta, 29, 30-38.
32. Gomez, L.M. et al. (2008) Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum. Reprod., 23, 709-715
33. Ferretti, C. et al. (2007) Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum. Reprod. Update, 13, 121-141.
34. Hirano, T. et al. (1999) CD9 is involved in invasion of human trophoblastlike choriocarcinoma cell line, BeWo cells. Mol. Hum. Reprod., 5, 168-174
35. Graham, F.L. et al. (1973) Transformation of rat cells by DNA of human adenovirus 5. Virology, 54, 536-539.
36. Lesouhaitier, O. et al. (2001) Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing channel expression. Endocrinology, 142, 4320-4330.
37. Bordier, C. (1981) Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem., 256, 1604-1607.
38. Kazemi, S. et al. (2004) Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death. Mol. Cell. Biol., 24, 3415-3429.
39. Disbrow, G.L. et al. (2005) Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J. Virol., 79, 5839-5846.
40. Androphy, E.J. et al. (1987) Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J., 6, 989-992.
41. You, H. et al. (2002) Defective 3A trophoblast-endometrial cell adhesion and altered 3A growth and survival by human papillomavirus type 16 oncogenes. Mol. Cancer Res., 1, 25-31.
42. Janneau, J.L. et al. (2002) Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J. Clin. Endocrinol. Metab., 87, 5336-5339.
43. Disbrow, G.L. et al. (2003) Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology, 311, 105-114.
44. Hu, L. et al. (2009) Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion. Virology, 384, 125-134.
45. Marianayagam, N.J. et al. (2004) The power of two: protein dimerization in biology. Trends Biochem. Sci., 29, 618-625.
46. DiMaio, D. et al. (2001) Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene, 20, 7866-7873.
47. Auvinen, E. et al. (2004) Human papillomavirus type 16 E5 protein colocalizes with the antiapoptotic Bcl-2 protein. Arch. Virol., 149, 1745-1759
48. Kabsch, K. et al. (2002) The human papillomavirus type 16 (HPV-16) E5 protein sensitizes human keratinocytes to apoptosis induced by osmotic stress. Oncogene, 21, 947-953.
49. Pater, M.M. et al. (1985) Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology, 145, 313-318.
50. Stoler, M.H. et al. (1992) Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol., 23, 117-128.
51. Bowen, J.M. et al. (2002) Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta, 23, 239-256.
52. Whiteside, M.A. et al. (2008) Human papillomavirus and molecular considerations for cancer risk. Cancer, 113, 2981-2994.
53. Wells, A. et al. (2008) E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin. Exp. Metastasis, 25, 621-628.
54. Pokutta, S. et al. (2007) Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu. Rev. Cell Dev. Biol., 23, 237-261.
55. Kuphal, S. et al. (2004) Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene, 23, 8509-8519.
56. Criswell, T.L. et al. (2007) Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility. J. Biol. Chem., 282, 32491-32500.
57. Bachelder, R.E. et al. (2005) Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J. Cell Biol., 168, 29-33.
58. Kim, H.J. et al. (2007) Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol. Cell. Biol., 27, 3165-3175.
59. Chiarugi, P. et al. (2008) Anoikis: a necessary death program for anchoragedependent cells. Biochem. Pharmacol., 76, 1352-1364.
60. Kim, S.H. et al. (2009) Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein. Carcinogenesis, 30, 753-757.